News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
413,310 Results
Type
Article (19533)
Company Profile (119)
Press Release (393649)
Multimedia
Podcasts (69)
Webinars (14)
Section
Business (121289)
Career Advice (717)
Deals (23649)
Drug Delivery (88)
Drug Development (56463)
Employer Resources (68)
FDA (9934)
Job Trends (8604)
News (214946)
Policy (20004)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (914)
Accelerated approval (24)
Adcomms (13)
Allergies (94)
Alliances (30279)
ALS (114)
Alzheimer's disease (982)
Antibody-drug conjugate (ADC) (206)
Approvals (10230)
Artificial intelligence (319)
Autoimmune disease (97)
Automation (19)
Bankruptcy (226)
Best Places to Work (6610)
BIOSECURE Act (10)
Biosimilars (129)
Biotechnology (51)
Bladder cancer (120)
Brain cancer (45)
Breast cancer (374)
Cancer (3186)
Cardiovascular disease (248)
Career advice (641)
Career pathing (16)
CAR-T (197)
CDC (15)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (26)
Clinical research (49804)
Collaboration (1069)
Compensation (486)
Complete response letters (44)
COVID-19 (1286)
CRISPR (59)
C-suite (559)
Cystic fibrosis (90)
Data (4488)
Denatured (21)
Depression (86)
Diabetes (274)
Diagnostics (3297)
Digital health (18)
Diversity (5)
Diversity, equity & inclusion (20)
Drug discovery (162)
Drug pricing (139)
Drug shortages (24)
Duchenne muscular dystrophy (160)
Earnings (54095)
Editorial (32)
Employer branding (5)
Employer resources (60)
Events (60378)
Executive appointments (662)
FDA (12189)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (827)
Gene editing (126)
Generative AI (28)
Gene therapy (370)
GLP-1 (591)
Government (2269)
Grass and pollen (5)
Guidances (324)
Healthcare (8327)
HIV (35)
Huntington's disease (20)
IgA nephropathy (76)
Immunology and inflammation (132)
Immuno-oncology (32)
Indications (86)
Infectious disease (1426)
Inflammatory bowel disease (127)
Inflation Reduction Act (8)
Influenza (60)
Intellectual property (196)
Interviews (100)
IPO (10967)
IRA (40)
Job creations (2322)
Job search strategy (554)
JPM (35)
Kidney cancer (12)
Labor market (39)
Layoffs (237)
Leadership (13)
Legal (4422)
Liver cancer (57)
Longevity (9)
Lung cancer (427)
Lymphoma (284)
Machine learning (27)
Management (23)
Manufacturing (555)
MASH (123)
Medical device (5643)
Medtech (5671)
Mergers & acquisitions (13485)
Metabolic disorders (758)
Multiple sclerosis (105)
NASH (16)
Neurodegenerative disease (172)
Neuropsychiatric disorders (55)
Neuroscience (1791)
Neurotech (1)
NextGen: Class of 2026 (2685)
Non-profit (1216)
Now hiring (17)
Obesity (350)
Opinion (199)
Ovarian cancer (122)
Pain (158)
Pancreatic cancer (160)
Parkinson's disease (188)
Partnered (18)
Patents (384)
Patient recruitment (337)
Peanut (26)
People (36306)
Pharmaceutical (66)
Pharmacy benefit managers (22)
Phase 1 (15095)
Phase 2 (21846)
Phase 3 (16963)
Pipeline (3929)
Policy (175)
Postmarket research (1642)
Preclinical (5898)
Press Release (32)
Prostate cancer (158)
Psychedelics (27)
Radiopharmaceuticals (192)
Rare diseases (574)
Real estate (3213)
Recruiting (24)
Regulatory (16238)
Reports (23)
Research institute (974)
Resumes & cover letters (89)
Rett syndrome (23)
RNA editing (10)
RSV (37)
Schizophrenia (114)
Series A (141)
Series B (102)
Service/supplier (4)
Sickle cell disease (73)
Special edition (11)
Spinal muscular atrophy (96)
Sponsored (24)
Startups (2012)
State (2)
Stomach cancer (11)
Supply chain (70)
Tariffs (72)
The Weekly (46)
Vaccines (426)
Venture capital (49)
Weight loss (215)
Women's health (37)
Worklife (9)
Date
Today (6)
Last 7 days (372)
Last 30 days (1464)
Last 365 days (20122)
2026 (1866)
2025 (20348)
2024 (23158)
2023 (26081)
2022 (33045)
2021 (34275)
2020 (32187)
2019 (23603)
2018 (17974)
2017 (20130)
2016 (18370)
2015 (22006)
2014 (16825)
2013 (13797)
2012 (14600)
2011 (15378)
2010 (14158)
Location
Africa (430)
Alabama (42)
Alaska (3)
Arizona (127)
Arkansas (6)
Asia (29490)
Australia (5918)
California (7096)
Canada (2348)
China (856)
Colorado (322)
Connecticut (339)
Delaware (206)
Europe (56967)
Florida (1144)
Georgia (156)
Hawaii (2)
Idaho (15)
Illinois (529)
India (58)
Indiana (336)
Iowa (2)
Japan (320)
Kansas (86)
Kentucky (24)
Louisiana (15)
Maine (46)
Maryland (849)
Massachusetts (5198)
Michigan (125)
Minnesota (310)
Mississippi (1)
Missouri (83)
Montana (13)
Nebraska (15)
Nevada (89)
New Hampshire (53)
New Jersey (2314)
New Mexico (11)
New York (2035)
North Carolina (986)
North Dakota (3)
Northern California (3442)
Ohio (170)
Oklahoma (6)
Oregon (25)
Pennsylvania (1492)
Puerto Rico (19)
Rhode Island (23)
South America (673)
South Carolina (50)
Southern California (2865)
Tennessee (111)
Texas (1084)
United States (25731)
Utah (163)
Virginia (203)
Washington D.C. (51)
Washington State (628)
West Virginia (3)
Wisconsin (57)
Wyoming (1)
413,310 Results for "alembic pharmaceuticals limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Press Releases
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience
May 14, 2025
·
3 min read
Press Releases
AABB To Run Limited-Time Certified Advanced Biotherapies Professional (CABP) Free Exam Retake Offer
December 1, 2025
·
1 min read
Press Releases
Haemonetics Acquires Vivasure Medical Limited
January 9, 2026
·
5 min read
Business
Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva® (Docosanol Cream 10%) Including the First Approval in the Pump Format
Cosette Pharmaceuticals, Inc (“Cosette”), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (“Alembic”; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva® (Docosanol cream 10%) in a 2 gm tube and pump formats.
May 24, 2022
·
2 min read
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY26
January 29, 2026
·
7 min read
Press Releases
Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
December 10, 2025
·
6 min read
Press Releases
Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited
January 28, 2026
·
2 min read
Press Releases
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
October 15, 2025
·
5 min read
Press Releases
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
December 8, 2025
·
6 min read
1 of 41,331
Next
